L. bulgaricus and S. thermophilus: 7% Lower Mortality Risk

Three million people. Fifty prospective cohort studies. The signal that emerges from this body of evidence is as consistent as epidemiology gets: each additional daily serving of yogurt is associated with a 7% lower risk of dying from any cause (RR = 0.933, p < 0.001). Among all fermented foods analyzed — including fermented vegetables, legumes, fish, and beverages — fermented dairy produced the most statistically robust and consistent protective associations with longevity.

This is not a single study finding. It is a pooled estimate drawn from half a century of prospective cohort research, synthesized by Matalas and colleagues at institutions across Europe and published in Frontiers in Nutrition in 2026. The dose-response relationship was consistent across cause-specific outcomes: cardiovascular mortality fell by 7% per serving (RR = 0.932, p < 0.001), and cancer mortality by 6% (RR = 0.940, p = 0.04). That cardiovascular and cancer mortality track together — and independently — points toward a shared upstream mechanism rather than a disease-specific effect.

Key Findings

RR = relative risk per additional daily serving of yogurt. Meta-analysis of 50 prospective cohort studies, n > 3,000,000 participants. Matalas et al., Front Nutr. 2026;13:1714437.

Mechanism: How L. bulgaricus and S. thermophilus Act on Systemic Inflammation

ACE-Inhibiting Peptides and NF-κB Suppression

During fermentation, Lactobacillus delbrueckii subsp. bulgaricus and Streptococcus thermophilus hydrolyze milk proteins — primarily casein and whey — into bioactive peptides. Among the most studied are the tripeptides Val-Pro-Pro (VPP) and Ile-Pro-Pro (IPP), which inhibit angiotensin-converting enzyme (ACE). ACE drives the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor and activator of aldosterone, which raises blood pressure and promotes vascular inflammation. By inhibiting ACE, VPP and IPP reduce the angiotensin II load — lowering both blood pressure and downstream activation of NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells). NF-κB is the master transcription factor controlling expression of pro-inflammatory cytokines including interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α). Chronic NF-κB activation and elevated IL-6 are independently associated with cardiovascular mortality and cancer progression across multiple longitudinal datasets. The same fermentation process also produces conjugated linoleic acid (CLA) and short-chain fatty acids (SCFAs), which reduce LDL cholesterol synthesis in hepatocytes and further attenuate IL-6 secretion from macrophages. These are not single-target molecules — they act across several inflammatory nodes simultaneously, which may help explain why the protective signal in this meta-analysis reaches across multiple cause-of-death categories rather than clustering around a single disease.

Epithelial Barrier Reinforcement and LPS Translocation

The second pathway operates at the gut wall. Tight-junction proteins — particularly claudin-1 and occludin — form the molecular seal between adjacent intestinal epithelial cells. When this seal is compromised, lipopolysaccharide (LPS), a structural component of the outer membrane of gram-negative bacteria residing in the colon, translocates into portal and systemic circulation. Even at sub-clinical concentrations, circulating LPS activates Toll-like receptor 4 (TLR4) on innate immune cells, sustaining a state of chronic low-grade endotoxemia. This endotoxemia is mechanistically linked to atherosclerotic plaque progression, insulin resistance, and polarization of the tumor microenvironment — all of which elevate cardiovascular and cancer mortality risk over time. L. bulgaricus and S. thermophilus upregulate claudin-1 and occludin expression in intestinal epithelial cells, tightening the paracellular seal and reducing LPS translocation. The result is a lower systemic endotoxin load — and, cumulatively, a reduction in the inflammatory milieu that drives the chronic disease trajectories leading to premature death. This mechanism is fully consistent with the parallel reductions in both cardiovascular and cancer mortality observed in the meta-analysis: both diseases share sustained systemic inflammation as a common upstream driver.

Vital Yogurts Connection: Classic Yogurt

Classic Yogurt is fermented with the same two cultures — Lactobacillus delbrueckii subsp. bulgaricus and Streptococcus thermophilus — that drove the longevity associations documented across these 50 cohort studies. This matters because the protective compounds identified in the mechanistic literature — VPP, IPP, CLA, SCFAs, and the tight-junction-stabilizing metabolites — are produced by live, metabolically active cultures during fermentation. They are not present in heat-treated dairy products. Pasteurization applied after fermentation destroys the cultures and the enzymatic activity responsible for producing them. Vital's Classic Yogurt is not heat-treated post-fermentation: the cultures remain alive and metabolically active at the time of consumption, preserving the bioactive peptide production that characterizes traditional yogurt fermentation.

The associations documented in this meta-analysis were built from populations consuming conventional yogurt — the kind available across grocery stores in multiple countries over several decades. Vital's Classic Yogurt uses the same foundational cultures, in a live-culture format, from fresh milk. The bioactive compounds these cohort populations were presumably consuming are present in a daily serving of Classic Yogurt. Daily consistency is what the cohort data reflects — not an intervention, but a habit maintained across years.

Protocol Implications

Because this is a meta-analysis of prospective observational cohorts, the protocol implications are drawn from population-level associations rather than a controlled intervention with a defined endpoint. The dose-response unit is one serving per day: researchers modeled risk as a function of each additional daily serving consumed. The populations studied were consuming yogurt habitually across years, not as a defined clinical course. This suggests the relevant variable is not a 4-week intervention but a sustained daily practice. The mechanistic data on VPP and IPP peptide accumulation, NF-κB downregulation, and tight-junction protein upregulation are consistent with this interpretation — these are cumulative processes, not acute ones. One serving per day, maintained consistently over months and years, is the consumption pattern that maps to what was actually observed in these cohort populations. No study within this meta-analysis examined the minimum duration required to establish the mortality associations reported here, and this analysis cannot tell us whether shorter periods of consumption carry any detectable signal.

Vital Yogurts — Classic Yogurt

The cultures studied are in Classic Yogurt.

Lactobacillus delbrueckii subsp. bulgaricus · Streptococcus thermophilus

A meta-analysis of 50 cohort studies found each daily yogurt serving associated with 7% lower all-cause mortality and 7% lower cardiovascular mortality. Classic Yogurt is fermented with the same two cultures — live and metabolically active at consumption — that produced the bioactive peptides and fermentation metabolites documented across this body of research.

Valley — 20B CFU Reserve — 40B CFU Summit — 60B CFU

Shop Classic Yogurt

This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before making changes to your diet or supplement routine. The studies cited are referenced for informational context; Vital Yogurts makes no therapeutic or disease treatment claims.